Global Prevalence of ATTR-CM in Participants With HFpEF

Clinical trial NCT04424914 · TERMINATED

Trial details

NCT number: NCT04424914
Sponsor: Pfizer
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Transthyretin Amyloid Cardiomyopathy Heart Failure With Preserved Ejection Fraction

Start date: 2020-12-30
Primary completion: 2023-06-02
Enrollment: 347

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.